HDAC6 and breast carcinoma: Given the importance of HDAC6 and Hsp90 in TNBC metastasis and the ongoing development of breast cancer-targeting drugs, this study was conducted to find novel dual HDAC6 and Hsp90 inhibitors using e-pharmacophore modeling, screening, molecular docking, and MM-GBSA calculations to calculate the binding affinity towards the two targets.